Telomir Pharmaceuticals公司宣布,其研发的Telomir-1药物能够选择性杀灭侵袭性三阴性乳腺癌细胞,这一发现为治疗这种难治性癌症提供了新的希望。
Telomir Pharmaceuticals公司宣布,其研发的Telomir-1药物能够选择性杀灭侵袭性三阴性乳腺癌细胞,这一发现为治疗这种难治性癌症提供了新的希望。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.